nodes	percent_of_prediction	percent_of_DWPC	metapath
Dactinomycin—ocular cancer—muscle cancer	0.165	0.266	CtDrD
Dactinomycin—uterine cancer—muscle cancer	0.103	0.166	CtDrD
Dactinomycin—ABCC6—Etoposide—muscle cancer	0.0905	0.276	CbGbCtD
Dactinomycin—testicular cancer—muscle cancer	0.077	0.124	CtDrD
Dactinomycin—germ cell cancer—muscle cancer	0.0737	0.119	CtDrD
Dactinomycin—kidney cancer—muscle cancer	0.0687	0.11	CtDrD
Dactinomycin—peripheral nervous system neoplasm—muscle cancer	0.068	0.109	CtDrD
Dactinomycin—sarcoma—muscle cancer	0.0655	0.105	CtDrD
Dactinomycin—ABCC6—Doxorubicin—muscle cancer	0.0618	0.189	CbGbCtD
Dactinomycin—ABCC1—Vincristine—muscle cancer	0.0291	0.089	CbGbCtD
Dactinomycin—ABCC1—Etoposide—muscle cancer	0.0267	0.0815	CbGbCtD
Dactinomycin—ABCG2—Vincristine—muscle cancer	0.0195	0.0595	CbGbCtD
Dactinomycin—ABCC1—Doxorubicin—muscle cancer	0.0182	0.0556	CbGbCtD
Dactinomycin—ABCG2—Etoposide—muscle cancer	0.0179	0.0546	CbGbCtD
Dactinomycin—ABCC1—Methotrexate—muscle cancer	0.0176	0.0539	CbGbCtD
Dactinomycin—ABCG2—Doxorubicin—muscle cancer	0.0122	0.0372	CbGbCtD
Dactinomycin—ABCG2—Methotrexate—muscle cancer	0.0118	0.036	CbGbCtD
Dactinomycin—ABCB1—Vincristine—muscle cancer	0.00703	0.0215	CbGbCtD
Dactinomycin—ABCB1—Etoposide—muscle cancer	0.00644	0.0197	CbGbCtD
Dactinomycin—ABCB1—Doxorubicin—muscle cancer	0.0044	0.0134	CbGbCtD
Dactinomycin—ABCB1—Methotrexate—muscle cancer	0.00426	0.013	CbGbCtD
Dactinomycin—Venoocclusive liver disease—Vincristine—muscle cancer	0.00326	0.067	CcSEcCtD
Dactinomycin—Radiation recall reaction (dermatologic)—Etoposide—muscle cancer	0.00218	0.0447	CcSEcCtD
Dactinomycin—Neutropenic sepsis—Etoposide—muscle cancer	0.00206	0.0423	CcSEcCtD
Dactinomycin—Recall phenomenon—Etoposide—muscle cancer	0.00206	0.0423	CcSEcCtD
Dactinomycin—ABCC6—Podofilox—Etoposide—muscle cancer	0.00183	1	CbGdCrCtD
Dactinomycin—Radiation injury—Doxorubicin—muscle cancer	0.00177	0.0363	CcSEcCtD
Dactinomycin—Multi-organ failure—Vincristine—muscle cancer	0.00135	0.0278	CcSEcCtD
Dactinomycin—Radiation recall reaction (dermatologic)—Doxorubicin—muscle cancer	0.00113	0.0232	CcSEcCtD
Dactinomycin—Neutropenic sepsis—Doxorubicin—muscle cancer	0.00107	0.022	CcSEcCtD
Dactinomycin—Recall phenomenon—Doxorubicin—muscle cancer	0.00107	0.022	CcSEcCtD
Dactinomycin—Myelosuppression—Vincristine—muscle cancer	0.00094	0.0193	CcSEcCtD
Dactinomycin—Ascites—Etoposide—muscle cancer	0.000786	0.0162	CcSEcCtD
Dactinomycin—Myelosuppression—Etoposide—muscle cancer	0.000762	0.0157	CcSEcCtD
Dactinomycin—Proctitis—Doxorubicin—muscle cancer	0.000759	0.0156	CcSEcCtD
Dactinomycin—Febrile neutropenia—Vincristine—muscle cancer	0.000733	0.0151	CcSEcCtD
Dactinomycin—Febrile neutropenia—Etoposide—muscle cancer	0.000594	0.0122	CcSEcCtD
Dactinomycin—Multi-organ failure—Doxorubicin—muscle cancer	0.000568	0.0117	CcSEcCtD
Dactinomycin—Extravasation—Vincristine—muscle cancer	0.000505	0.0104	CcSEcCtD
Dactinomycin—Raised liver function tests—Methotrexate—muscle cancer	0.000463	0.00953	CcSEcCtD
Dactinomycin—Ulcerative stomatitis—Methotrexate—muscle cancer	0.000463	0.00953	CcSEcCtD
Dactinomycin—Hepatotoxicity—Etoposide—muscle cancer	0.000463	0.00951	CcSEcCtD
Dactinomycin—Necrosis—Etoposide—muscle cancer	0.000455	0.00936	CcSEcCtD
Dactinomycin—Extravasation—Etoposide—muscle cancer	0.000409	0.00842	CcSEcCtD
Dactinomycin—Ascites—Doxorubicin—muscle cancer	0.000408	0.00838	CcSEcCtD
Dactinomycin—Ulcerative stomatitis—Doxorubicin—muscle cancer	0.000401	0.00825	CcSEcCtD
Dactinomycin—Mouth ulceration—Vincristine—muscle cancer	0.000399	0.0082	CcSEcCtD
Dactinomycin—Myelosuppression—Doxorubicin—muscle cancer	0.000395	0.00812	CcSEcCtD
Dactinomycin—Ulcer—Etoposide—muscle cancer	0.000378	0.00776	CcSEcCtD
Dactinomycin—Hepatic failure—Vincristine—muscle cancer	0.000356	0.00732	CcSEcCtD
Dactinomycin—Febrile neutropenia—Methotrexate—muscle cancer	0.000356	0.00731	CcSEcCtD
Dactinomycin—Eruption—Methotrexate—muscle cancer	0.000348	0.00715	CcSEcCtD
Dactinomycin—Folliculitis—Methotrexate—muscle cancer	0.00034	0.007	CcSEcCtD
Dactinomycin—Oesophagitis—Etoposide—muscle cancer	0.000326	0.00671	CcSEcCtD
Dactinomycin—Mouth ulceration—Etoposide—muscle cancer	0.000323	0.00664	CcSEcCtD
Dactinomycin—Sepsis—Etoposide—muscle cancer	0.00031	0.00637	CcSEcCtD
Dactinomycin—Febrile neutropenia—Doxorubicin—muscle cancer	0.000308	0.00633	CcSEcCtD
Dactinomycin—Eruption—Doxorubicin—muscle cancer	0.000301	0.00619	CcSEcCtD
Dactinomycin—Phlebitis—Etoposide—muscle cancer	0.000301	0.00619	CcSEcCtD
Dactinomycin—Folliculitis—Doxorubicin—muscle cancer	0.000295	0.00606	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Vincristine—muscle cancer	0.000288	0.00593	CcSEcCtD
Dactinomycin—Hepatotoxicity—Methotrexate—muscle cancer	0.000277	0.0057	CcSEcCtD
Dactinomycin—Necrosis—Methotrexate—muscle cancer	0.000273	0.0056	CcSEcCtD
Dactinomycin—Pancytopenia—Vincristine—muscle cancer	0.000263	0.0054	CcSEcCtD
Dactinomycin—Hepatomegaly—Doxorubicin—muscle cancer	0.000262	0.00538	CcSEcCtD
Dactinomycin—Neutropenia—Vincristine—muscle cancer	0.000259	0.00532	CcSEcCtD
Dactinomycin—Pneumonia—Vincristine—muscle cancer	0.000248	0.0051	CcSEcCtD
Dactinomycin—Extravasation—Methotrexate—muscle cancer	0.000245	0.00504	CcSEcCtD
Dactinomycin—Stomatitis—Vincristine—muscle cancer	0.00024	0.00494	CcSEcCtD
Dactinomycin—Necrosis—Doxorubicin—muscle cancer	0.000236	0.00485	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.000233	0.0048	CcSEcCtD
Dactinomycin—Ulcer—Methotrexate—muscle cancer	0.000226	0.00465	CcSEcCtD
Dactinomycin—Dysphagia—Etoposide—muscle cancer	0.000224	0.00461	CcSEcCtD
Dactinomycin—Pancytopenia—Etoposide—muscle cancer	0.000213	0.00438	CcSEcCtD
Dactinomycin—Extravasation—Doxorubicin—muscle cancer	0.000212	0.00437	CcSEcCtD
Dactinomycin—Neutropenia—Etoposide—muscle cancer	0.00021	0.00431	CcSEcCtD
Dactinomycin—Hypocalcaemia—Doxorubicin—muscle cancer	0.000202	0.00416	CcSEcCtD
Dactinomycin—Pneumonia—Etoposide—muscle cancer	0.000201	0.00413	CcSEcCtD
Dactinomycin—Aplastic anaemia—Methotrexate—muscle cancer	0.000201	0.00413	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.000198	0.00407	CcSEcCtD
Dactinomycin—Ulcer—Doxorubicin—muscle cancer	0.000196	0.00403	CcSEcCtD
Dactinomycin—Alopecia—Vincristine—muscle cancer	0.000196	0.00402	CcSEcCtD
Dactinomycin—Stomatitis—Etoposide—muscle cancer	0.000195	0.004	CcSEcCtD
Dactinomycin—Mouth ulceration—Methotrexate—muscle cancer	0.000193	0.00398	CcSEcCtD
Dactinomycin—Agranulocytosis—Etoposide—muscle cancer	0.000186	0.00383	CcSEcCtD
Dactinomycin—Sepsis—Methotrexate—muscle cancer	0.000186	0.00382	CcSEcCtD
Dactinomycin—Anaemia—Vincristine—muscle cancer	0.000178	0.00366	CcSEcCtD
Dactinomycin—Aplastic anaemia—Doxorubicin—muscle cancer	0.000174	0.00358	CcSEcCtD
Dactinomycin—Hepatic failure—Methotrexate—muscle cancer	0.000173	0.00355	CcSEcCtD
Dactinomycin—Leukopenia—Vincristine—muscle cancer	0.000173	0.00355	CcSEcCtD
Dactinomycin—Erythema multiforme—Etoposide—muscle cancer	0.00017	0.00349	CcSEcCtD
Dactinomycin—Oesophagitis—Doxorubicin—muscle cancer	0.000169	0.00348	CcSEcCtD
Dactinomycin—Mouth ulceration—Doxorubicin—muscle cancer	0.000167	0.00344	CcSEcCtD
Dactinomycin—Flushing—Etoposide—muscle cancer	0.000166	0.00342	CcSEcCtD
Dactinomycin—Myalgia—Vincristine—muscle cancer	0.000164	0.00337	CcSEcCtD
Dactinomycin—Chills—Etoposide—muscle cancer	0.000161	0.00331	CcSEcCtD
Dactinomycin—Sepsis—Doxorubicin—muscle cancer	0.000161	0.00331	CcSEcCtD
Dactinomycin—Alopecia—Etoposide—muscle cancer	0.000158	0.00326	CcSEcCtD
Dactinomycin—Lethargy—Methotrexate—muscle cancer	0.000158	0.00326	CcSEcCtD
Dactinomycin—Oedema—Vincristine—muscle cancer	0.000157	0.00323	CcSEcCtD
Dactinomycin—Infection—Vincristine—muscle cancer	0.000156	0.00321	CcSEcCtD
Dactinomycin—Phlebitis—Doxorubicin—muscle cancer	0.000156	0.00321	CcSEcCtD
Dactinomycin—Thrombocytopenia—Vincristine—muscle cancer	0.000154	0.00317	CcSEcCtD
Dactinomycin—Anorexia—Vincristine—muscle cancer	0.00015	0.00308	CcSEcCtD
Dactinomycin—Hepatic failure—Doxorubicin—muscle cancer	0.00015	0.00308	CcSEcCtD
Dactinomycin—Ill-defined disorder—Etoposide—muscle cancer	0.000145	0.00298	CcSEcCtD
Dactinomycin—Anaemia—Etoposide—muscle cancer	0.000144	0.00297	CcSEcCtD
Dactinomycin—Liver function test abnormal—Methotrexate—muscle cancer	0.000143	0.00295	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000143	0.00295	CcSEcCtD
Dactinomycin—Malaise—Etoposide—muscle cancer	0.000141	0.0029	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00014	0.00288	CcSEcCtD
Dactinomycin—Leukopenia—Etoposide—muscle cancer	0.00014	0.00287	CcSEcCtD
Dactinomycin—Lethargy—Doxorubicin—muscle cancer	0.000137	0.00282	CcSEcCtD
Dactinomycin—Decreased appetite—Vincristine—muscle cancer	0.000137	0.00281	CcSEcCtD
Dactinomycin—Fatigue—Vincristine—muscle cancer	0.000136	0.00279	CcSEcCtD
Dactinomycin—Pain—Vincristine—muscle cancer	0.000135	0.00277	CcSEcCtD
Dactinomycin—Discomfort—Etoposide—muscle cancer	0.000131	0.0027	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Vincristine—muscle cancer	0.000129	0.00265	CcSEcCtD
Dactinomycin—Pancytopenia—Methotrexate—muscle cancer	0.000127	0.00262	CcSEcCtD
Dactinomycin—Infection—Etoposide—muscle cancer	0.000127	0.0026	CcSEcCtD
Dactinomycin—Neutropenia—Methotrexate—muscle cancer	0.000125	0.00258	CcSEcCtD
Dactinomycin—Thrombocytopenia—Etoposide—muscle cancer	0.000125	0.00257	CcSEcCtD
Dactinomycin—Abdominal pain—Vincristine—muscle cancer	0.000124	0.00256	CcSEcCtD
Dactinomycin—Body temperature increased—Vincristine—muscle cancer	0.000124	0.00256	CcSEcCtD
Dactinomycin—Liver function test abnormal—Doxorubicin—muscle cancer	0.000124	0.00255	CcSEcCtD
Dactinomycin—Anorexia—Etoposide—muscle cancer	0.000121	0.0025	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000121	0.00249	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000121	0.00249	CcSEcCtD
Dactinomycin—Pneumonia—Methotrexate—muscle cancer	0.00012	0.00248	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000119	0.00244	CcSEcCtD
Dactinomycin—Stomatitis—Methotrexate—muscle cancer	0.000117	0.0024	CcSEcCtD
Dactinomycin—Dysphagia—Doxorubicin—muscle cancer	0.000116	0.00239	CcSEcCtD
Dactinomycin—Hypersensitivity—Vincristine—muscle cancer	0.000116	0.00238	CcSEcCtD
Dactinomycin—Asthenia—Vincristine—muscle cancer	0.000113	0.00232	CcSEcCtD
Dactinomycin—Agranulocytosis—Methotrexate—muscle cancer	0.000112	0.0023	CcSEcCtD
Dactinomycin—Decreased appetite—Etoposide—muscle cancer	0.000111	0.00228	CcSEcCtD
Dactinomycin—Pancytopenia—Doxorubicin—muscle cancer	0.00011	0.00227	CcSEcCtD
Dactinomycin—Fatigue—Etoposide—muscle cancer	0.00011	0.00226	CcSEcCtD
Dactinomycin—Pain—Etoposide—muscle cancer	0.000109	0.00224	CcSEcCtD
Dactinomycin—Neutropenia—Doxorubicin—muscle cancer	0.000109	0.00223	CcSEcCtD
Dactinomycin—Diarrhoea—Vincristine—muscle cancer	0.000108	0.00221	CcSEcCtD
Dactinomycin—Hepatitis—Methotrexate—muscle cancer	0.000107	0.00221	CcSEcCtD
Dactinomycin—Pharyngitis—Methotrexate—muscle cancer	0.000107	0.00219	CcSEcCtD
Dactinomycin—Feeling abnormal—Etoposide—muscle cancer	0.000105	0.00216	CcSEcCtD
Dactinomycin—Pneumonia—Doxorubicin—muscle cancer	0.000104	0.00214	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Etoposide—muscle cancer	0.000104	0.00214	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000103	0.00211	CcSEcCtD
Dactinomycin—Erythema multiforme—Methotrexate—muscle cancer	0.000102	0.00209	CcSEcCtD
Dactinomycin—Stomatitis—Doxorubicin—muscle cancer	0.000101	0.00208	CcSEcCtD
Dactinomycin—Body temperature increased—Etoposide—muscle cancer	0.000101	0.00207	CcSEcCtD
Dactinomycin—Abdominal pain—Etoposide—muscle cancer	0.000101	0.00207	CcSEcCtD
Dactinomycin—Vomiting—Vincristine—muscle cancer	0.0001	0.00206	CcSEcCtD
Dactinomycin—Rash—Vincristine—muscle cancer	9.92e-05	0.00204	CcSEcCtD
Dactinomycin—Agranulocytosis—Doxorubicin—muscle cancer	9.67e-05	0.00199	CcSEcCtD
Dactinomycin—Chills—Methotrexate—muscle cancer	9.64e-05	0.00198	CcSEcCtD
Dactinomycin—Alopecia—Methotrexate—muscle cancer	9.49e-05	0.00195	CcSEcCtD
Dactinomycin—Hypersensitivity—Etoposide—muscle cancer	9.39e-05	0.00193	CcSEcCtD
Dactinomycin—Erythema—Methotrexate—muscle cancer	9.35e-05	0.00192	CcSEcCtD
Dactinomycin—Nausea—Vincristine—muscle cancer	9.34e-05	0.00192	CcSEcCtD
Dactinomycin—Hepatitis—Doxorubicin—muscle cancer	9.3e-05	0.00191	CcSEcCtD
Dactinomycin—Pharyngitis—Doxorubicin—muscle cancer	9.23e-05	0.0019	CcSEcCtD
Dactinomycin—Asthenia—Etoposide—muscle cancer	9.14e-05	0.00188	CcSEcCtD
Dactinomycin—Erythema multiforme—Doxorubicin—muscle cancer	8.8e-05	0.00181	CcSEcCtD
Dactinomycin—Diarrhoea—Etoposide—muscle cancer	8.72e-05	0.00179	CcSEcCtD
Dactinomycin—Ill-defined disorder—Methotrexate—muscle cancer	8.68e-05	0.00178	CcSEcCtD
Dactinomycin—Anaemia—Methotrexate—muscle cancer	8.64e-05	0.00178	CcSEcCtD
Dactinomycin—Flushing—Doxorubicin—muscle cancer	8.63e-05	0.00178	CcSEcCtD
Dactinomycin—Malaise—Methotrexate—muscle cancer	8.43e-05	0.00173	CcSEcCtD
Dactinomycin—Leukopenia—Methotrexate—muscle cancer	8.37e-05	0.00172	CcSEcCtD
Dactinomycin—Chills—Doxorubicin—muscle cancer	8.35e-05	0.00172	CcSEcCtD
Dactinomycin—Alopecia—Doxorubicin—muscle cancer	8.22e-05	0.00169	CcSEcCtD
Dactinomycin—Vomiting—Etoposide—muscle cancer	8.1e-05	0.00167	CcSEcCtD
Dactinomycin—Erythema—Doxorubicin—muscle cancer	8.1e-05	0.00167	CcSEcCtD
Dactinomycin—Rash—Etoposide—muscle cancer	8.03e-05	0.00165	CcSEcCtD
Dactinomycin—Myalgia—Methotrexate—muscle cancer	7.96e-05	0.00164	CcSEcCtD
Dactinomycin—Discomfort—Methotrexate—muscle cancer	7.87e-05	0.00162	CcSEcCtD
Dactinomycin—Infection—Methotrexate—muscle cancer	7.58e-05	0.00156	CcSEcCtD
Dactinomycin—Nausea—Etoposide—muscle cancer	7.57e-05	0.00156	CcSEcCtD
Dactinomycin—Ill-defined disorder—Doxorubicin—muscle cancer	7.51e-05	0.00155	CcSEcCtD
Dactinomycin—Anaemia—Doxorubicin—muscle cancer	7.48e-05	0.00154	CcSEcCtD
Dactinomycin—Thrombocytopenia—Methotrexate—muscle cancer	7.47e-05	0.00154	CcSEcCtD
Dactinomycin—Malaise—Doxorubicin—muscle cancer	7.3e-05	0.0015	CcSEcCtD
Dactinomycin—Anorexia—Methotrexate—muscle cancer	7.27e-05	0.0015	CcSEcCtD
Dactinomycin—Leukopenia—Doxorubicin—muscle cancer	7.25e-05	0.00149	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Methotrexate—muscle cancer	6.95e-05	0.00143	CcSEcCtD
Dactinomycin—Myalgia—Doxorubicin—muscle cancer	6.89e-05	0.00142	CcSEcCtD
Dactinomycin—Discomfort—Doxorubicin—muscle cancer	6.81e-05	0.0014	CcSEcCtD
Dactinomycin—Decreased appetite—Methotrexate—muscle cancer	6.63e-05	0.00136	CcSEcCtD
Dactinomycin—Oedema—Doxorubicin—muscle cancer	6.61e-05	0.00136	CcSEcCtD
Dactinomycin—Fatigue—Methotrexate—muscle cancer	6.58e-05	0.00135	CcSEcCtD
Dactinomycin—Infection—Doxorubicin—muscle cancer	6.57e-05	0.00135	CcSEcCtD
Dactinomycin—Pain—Methotrexate—muscle cancer	6.53e-05	0.00134	CcSEcCtD
Dactinomycin—Thrombocytopenia—Doxorubicin—muscle cancer	6.47e-05	0.00133	CcSEcCtD
Dactinomycin—Anorexia—Doxorubicin—muscle cancer	6.3e-05	0.0013	CcSEcCtD
Dactinomycin—Feeling abnormal—Methotrexate—muscle cancer	6.29e-05	0.00129	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Methotrexate—muscle cancer	6.24e-05	0.00128	CcSEcCtD
Dactinomycin—Abdominal pain—Methotrexate—muscle cancer	6.03e-05	0.00124	CcSEcCtD
Dactinomycin—Body temperature increased—Methotrexate—muscle cancer	6.03e-05	0.00124	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	6.02e-05	0.00124	CcSEcCtD
Dactinomycin—Decreased appetite—Doxorubicin—muscle cancer	5.74e-05	0.00118	CcSEcCtD
Dactinomycin—Fatigue—Doxorubicin—muscle cancer	5.7e-05	0.00117	CcSEcCtD
Dactinomycin—Pain—Doxorubicin—muscle cancer	5.65e-05	0.00116	CcSEcCtD
Dactinomycin—Hypersensitivity—Methotrexate—muscle cancer	5.62e-05	0.00116	CcSEcCtD
Dactinomycin—Asthenia—Methotrexate—muscle cancer	5.48e-05	0.00113	CcSEcCtD
Dactinomycin—Feeling abnormal—Doxorubicin—muscle cancer	5.45e-05	0.00112	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Doxorubicin—muscle cancer	5.4e-05	0.00111	CcSEcCtD
Dactinomycin—Body temperature increased—Doxorubicin—muscle cancer	5.22e-05	0.00107	CcSEcCtD
Dactinomycin—Abdominal pain—Doxorubicin—muscle cancer	5.22e-05	0.00107	CcSEcCtD
Dactinomycin—Diarrhoea—Methotrexate—muscle cancer	5.22e-05	0.00107	CcSEcCtD
Dactinomycin—Hypersensitivity—Doxorubicin—muscle cancer	4.87e-05	0.001	CcSEcCtD
Dactinomycin—Vomiting—Methotrexate—muscle cancer	4.85e-05	0.000998	CcSEcCtD
Dactinomycin—Rash—Methotrexate—muscle cancer	4.81e-05	0.00099	CcSEcCtD
Dactinomycin—Asthenia—Doxorubicin—muscle cancer	4.74e-05	0.000975	CcSEcCtD
Dactinomycin—Nausea—Methotrexate—muscle cancer	4.53e-05	0.000932	CcSEcCtD
Dactinomycin—Diarrhoea—Doxorubicin—muscle cancer	4.52e-05	0.00093	CcSEcCtD
Dactinomycin—Vomiting—Doxorubicin—muscle cancer	4.2e-05	0.000864	CcSEcCtD
Dactinomycin—Rash—Doxorubicin—muscle cancer	4.17e-05	0.000857	CcSEcCtD
Dactinomycin—Nausea—Doxorubicin—muscle cancer	3.93e-05	0.000807	CcSEcCtD
